These smart dividend stocks are reliable investments that can help you generate steady passive income without stressing over market swings.
Author: techrossm
Tesla: The Big Beautiful Bill Isn’t Bullish For The Stock
Tesla faces rising political risks, subsidy cuts, and margin pressure as growth slows and regulatory headwinds mount. Find out why TSLA stock is a
Bitmine goes parabolic: 1,000% surge tied to massive Ethereum move and Tom Lee’s entry
BitMine Immersion stock skyrocketed by over 1,000% in a single day after revealing a bold $250 million Ethereum investment and naming crypto bull Tom
SEC Small Business Advisory Committee to Discuss Regulatory Framework for Finders and Continue Exploring Regulation A
The Securities and Exchange Commission’s Small Business Capital Formation Advisory Committee announced that it will hold a meeting at the SEC Headquarters in Washington
MintMiner+Coinbase is safer and more reliable. Start cloud mining to get cryptocurrency
In the era of rapid development of cryptocurrency, more and more users are eager to easily participate in the growth opportunities of mainstream currencies
Flagler County sheriff helps return money to victims of cryptocurrency scams
Flagler County Sheriff Rick Staly presented checks to two local victims of cryptocurrency scams last week. The sheriff’s office said this marks the first
Bullish Avadel Pharmaceuticals Insiders Loaded Up On US$761.7k Of Stock
However, When quite a few insiders buy shares, as it happened in Avadel Pharmaceuticals plc’s (NASDAQ:AVDL) case, it’s fantastic news for shareholders. Although we
Bullish Minerals 260 Insiders Loaded Up On AU$18.7m Of Stock
Quite a few insiders have dramatically grown their holdings in Minerals 260 Limited over the past 12 months. An insider’s optimism about the company’s
Wall Street investors are turning more bullish on stocks: Deutsche Bank
Much of the gains for U.S. stocks over the past few months have been powered by retail investors and corporations buying back their own
Bullish Sentiments for ImmunityBio (IBRX) After Trial Success and FDA Authorization
ImmunityBio, Inc. (NASDAQ:IBRX) is a clinical-stage immunotherapy company that develops next-generation therapies to treat cancer and infectious diseases. Its immunotherapy platform activates the …